Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects-Reference-Cited by-同舟云学术

Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects

Published:2017-04-13 Issue:7 Volume:13 Page:1653-1660
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Choi Won Suk¹,Noh Ji Yun¹,Song Joon Young¹,Cheong Hee Jin¹,Wie Seong-Heon²,Lee Jin Soo³,Lee Jacob⁴,Kim Shin-Woo⁵,Jeong Hye Won⁶,Jung Sook-In⁷,Kim Yeon-Sook⁸,Woo Heung Jeong⁴,Kim Kyung Ho⁹,Kim Hun⁹,Kim Woo Joo¹

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea

2. Division of Infectious Diseases, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

3. Division of Infectious Diseases, Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, Republic of Korea

4. Division of Infectious Diseases, Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Republic of Korea

5. Division of Allergic and Infectious Diseases, Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea

6. Division of Infectious Diseases, Department of Internal Medicine, Chungbuk University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea

7. Division of Infectious Diseases, Chonnam National University Medical School, Gwangju, Republic of Korea

8. Divisoin of Infectious Diseases, Chungnam National University School of Medicine, Daejeon, Republic of Korea

9. Life Science Research Institute, SK Chemicals, Seongnam, Gyeonggi-do, Republic of Korea

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1297351

Reference20 articles.

1. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

2. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity